Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

September 29, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its dentistry business, OraPharma, today announced the launch of OraTalks, a new podcast created to ignite meaningful dialogue and explore the challenges shaping modern dentistry.Season One of OraTalks features nine episodes covering timely topics in oral health and patient care, such as sleep disorders, women's health, social determinants, and...

Read more

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Administration (FDA) Type C Meeting Supporting the Development of Skinject

September 29, 2025 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce positive feedback from Type C meeting with United States Food and Drug Administration (FDA).The purpose of the Type C meeting was to discuss the design, endpoints, and other key protocol elements for the clinical...

Read more

Avant Brands Recognized as One of Canada's Top Growing Companies by The Globe and Mail for Third Consecutive Year

September 29, 2025 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced it has been recognized as one of Canada's Top Growing Companies in The Globe and Mail's 2025 Report on Business. This marks the third consecutive year Avant has earned a place on the list, ranking 138th with three-year revenue growth of 263%. Avant previously ranked #49 in 2023 and...

Read more

Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

September 29, 2025 6:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it has entered an agreement with Automated Technical Services to design and build a commercial-scale Mushroom Accelerator. This scaled-up system will produce Hypha's proprietary mushroom-based ingredients for sale to nutraceutical manufacturers worldwide.The Mushroom Accelerator is Hypha's breakthrough smart...

Read more

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization

September 29, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to provide an update on its proprietary Cladribine sublingual thin-film drug reformulation program (BNT23001), a next-generation delivery platform designed to improve bioavailability, patient adherence, and therapeutic outcomes in the treatment of neurological disorders,...

Read more

Angle PLC Announces Presentation of Data on Glioblastoma

September 29, 2025 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the presentation of new data from a proof-of-concept study in glioblastoma at the 7th Advances in Circulating Tumour Cells (ACTC) meeting, held 24-27 September 2025 in Thessaloniki, Greece.The poster entitled 'Detection of circulating...

Read more

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

September 29, 2025 12:00 AM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Nucro-Technics Inc. ("Nucro-Technics"), a Toronto-based contract research organization working in collaboration with Onco to conduct preclinical and analytical development services (see press release July 4, 2025), has initiated laboratory work under the Company's Investigational New Drug (IND) enabling program....

Read more

President Trump Clears the Path for Medical Marijuana Reform - But Why Is DEA Attorney Aarathi Haig Still Practicing Law with Ethical Violations

September 28, 2025 6:05 PM

In February 2025, the U.S. Department of Justice quietly admitted in federal court what patient advocates and constitutional lawyers have argued for years: the DEA's administrative law system is unconstitutional. In MMJ BioPharma Cultivation v. Bondi, DOJ conceded that the removal protections for DEA Administrative Law Judges violate Article II of the Constitution - and that the government would no longer defend them. This historic reversal...

Read more

Physician Practice IT at a Crossroads: Black Book Survey Finds Progress in Digital Tools but Gaps in Compliance, AI Trust, and Interoperability

September 26, 2025 5:00 PM

Black Book Research today released findings from its nationwide survey of 755 physician practice managers conducted July 15-September 15, 2025. The results present a split-screen view of physician practice technology: meaningful gains in digital adoption and compliance leadership, countered by alarming gaps in regulatory readiness, interoperability, and trust in artificial intelligence.The survey results will be discussed as thousands of...

Read more

Hundreds Attend IRA Implementation Summit; Uncertainties, Confusion and Concerns About Service Levels Underscore Dialogue

September 26, 2025 3:30 PM

On Thursday, September 25th, the American Society of Consultant Pharmacists (ASCP) hosted a half-day summit focused on the implementation of the Medicare Drug Price Negotiation Program of the Inflation Reduction Act (IRA) in long-term care (LTC) settings. Nearly 500 people registered for the hybrid conference and live streaming reached nearly 300. The meeting was held 98 days and 67 working days from implementation date on January 1st, 2026."As...

Read more

Aesthetic Surgery Center Wins First Place in Three Categories in the 2025 Best of Naples Community's Choice Awards

September 26, 2025 12:00 PM

The Aesthetic Surgery Center in Naples is proud to share that it has been recognized once again by the community through the 2025 Best of Naples Community's Choice Awards. This year, the practice received first place honors in three categories:Best Cosmetic/Plastic Surgery Center - Aesthetic Surgery CenterBest Plastic Surgeon - Dr. Anurag AgarwalBest Spa - Aesthetic Surgery CenterThese awards reflect the votes and support of patients and...

Read more

Certified Home Nursing Solutions Urges Communities to Respect Culture in Care

September 26, 2025 10:45 AM

Certified Home Nursing Solutions was recently featured in an in-depth interview that explored their journey, lessons, and outlook on personalised care. Founders Tasha Brown and Adrius King used the platform to call for greater awareness of cultural sensitivity in home care and to encourage communities to support seniors and individuals with disabilities by respecting their backgrounds."We saw our own family members get care that felt too...

Read more

Exousia Pro Reports Positive Outcome in Legal Proceeding

September 26, 2025 10:30 AM

Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on exosome-based therapies, today issued a positive update regarding its legal proceedings against Donald Steinberg, the former sole officer and director, and other related shareholders.Following a hearing held yesterday, the company is pleased to report that significant protections for shareholders have been put in place. While the motion for a Temporary...

Read more

CASI Pharmaceuticals Appoints James Huang to Board of Directors

September 26, 2025 9:45 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced the appointment of James Huang as an Independent Director to the CASI Board of Directors, effective as of October 1, 2025.Mr. Huang brings over 35 years of experience building and investing in biopharma companies globally. As Founder...

Read more

Medical Care Technologies Inc. Introduces AI-Powered Facial Analysis for Diabetic Retinopathy Detection

September 26, 2025 9:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) unveiled its AI Facial Health Risk Estimator for early detection of diabetic retinopathy, a leading cause of preventable blindness worldwide.The system analyzes subtle retinal cues captured from standard facial imaging, identifying microaneurysms, hemorrhages, and vascular leakage, allowing for non-invasive, accessible early screening."Diabetic retinopathy often goes undiagnosed until vision loss...

Read more

African Leaders Call for Bold, United Action to Tackle Global Health Crises and Sustain Malaria Progress

September 26, 2025 7:45 AM

African Heads of State and Government convened global leaders on Wednesday at a high-level event on the margins of the 80th United Nations General Assembly, sounding the alarm on escalating threats to global health security.Convened under the theme "Uniting for Global Health Security", the joint event brought together the Global Leaders Network for Women's, Children's and Adolescents' Health, chaired by H.E. President Cyril Ramaphosa of South...

Read more

Mending Kids to Host 8th Annual Hike 2 Mend, a Free Community Walk Supporting Surgical Care for Children

September 25, 2025 9:00 PM

Mending Kids, the nonprofit providing life-changing surgical care to children worldwide, will host its 8th annual Hike 2 Mend on Saturday, Sept. 27, 2025, at Cheeseboro & Palo Comado Canyon in Agoura Hills. The free, family- and dog-friendly event is presented by the Conrad Family.The morning brings families, supporters, and neighbors together to honor the journeys parents undertake to access critical medical care for their children and to help...

Read more

Wellgistics Health Announces Pricing of $5 Million Public Offering

September 25, 2025 8:01 PM

Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862 shares of common stock, together with warrants to purchase up to 7,142,862 shares of common stock at a combined public offering price of $0.70 per share and associated warrant. The warrants will have an exercise price of $0.70...

Read more

OPEN Healthcare Celebrates Grand Opening of 23,000 Sq. Ft. Innovative Diagnostic Laboratory and Launch of At-Home Testing Service in Gardena, California

September 25, 2025 5:00 PM

OPEN Healthcare proudly announces the grand opening of its new state-of-the-art 23,000-square-foot clinical laboratory in Gardena, California, marking a major milestone in its mission to expand access to high-quality, affordable testing worldwide.Built on the foundation of Seegene Medical Foundation (SMF), one of the leading reference laboratories in Korea - OPEN Healthcare continues its mission of making healthcare open and accessible to...

Read more

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

September 25, 2025 4:01 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025...

Read more